Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Oct;90(1):88–92. doi: 10.1111/j.1365-2249.1992.tb05837.x

Endothelial cell damage in primary biliary cirrhosis: influence of cholestasis and immunological mechanisms.

A D Blann 1, C Babbs 1, J M Neuberger 1
PMCID: PMC1554559  PMID: 1395104

Abstract

In a study looking for evidence of endothelial cell damage in primary biliary cirrhosis, serum from patients was found to be significantly more cytotoxic to cultured endothelial cells in vitro than normal control serum (P less than 0.001). Serum also contained higher levels of von Willebrand factor antigen (vWFAg, a specific product of the endothelium) than control serum (P less than 0.001). Cytotoxicity correlated with serum levels of vWFAg (P less than 0.05) and with serum bilirubin (P less than 0.05). No correlations were found between cytotoxicity and circulating immune complexes, C-reactive protein or CH50. The study was controlled by serum from patients with other liver diseases. In these samples vWFAg (P less than 0.003), and bilirubin levels (P less than 0.001) were also raised relative to normal controls. vWFAg levels again correlated with levels of bilirubin (P less than 0.05). Tissue culture experiments showed that purified bilirubin was cytotoxic to human umbilical vein endothelial cells and induced the release of vWFAg. The case report of a patient with obstructive jaundice again indicated that levels of bilirubin and vWFAg were related. These results suggest that endothelial cell damage occurs in both primary biliary cirrhosis and to a lesser extent in other liver diseases, and may be mediated by cholestasis, not by humoral immunological mechanisms.

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acute hepatitis B associated with gynaecological surgery. Lancet. 1980 Jan 5;1(8158):1–6. [PubMed] [Google Scholar]
  2. Adams D. H., Wang L., Hubscher S. G., Neuberger J. M. Hepatic endothelial cells. Targets in liver allograft rejection? Transplantation. 1989 Mar;47(3):479–482. doi: 10.1097/00007890-198903000-00016. [DOI] [PubMed] [Google Scholar]
  3. Berg P. A., Klein R., Lindenborn-Fotinos J. Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol. 1986;2(1):123–131. doi: 10.1016/s0168-8278(86)80015-0. [DOI] [PubMed] [Google Scholar]
  4. Blann A. D. Endothelial cell damage in rheumatoid disease correlates with complement consumption and immune complexes. Rheumatol Int. 1991;11(2):87–87. doi: 10.1007/BF00291152. [DOI] [PubMed] [Google Scholar]
  5. Blann A. D., Garner C. M. Indium 111 (111In) as a label for endothelial cells and fibroblasts used as target cells in cytotoxicity tests. Med Lab Sci. 1985 Jan;42(1):92–94. [PubMed] [Google Scholar]
  6. Blann A. D., Lewin I., Bacon P. A. Development and evaluation of a rapid, semi-automatic micro-method for CH50 estimation using a computer program. Immunol Invest. 1990 Apr;19(2):109–118. doi: 10.3109/08820139009042031. [DOI] [PubMed] [Google Scholar]
  7. Crowe J. P., Molloy M. G., Wells I., Thompson B. R., Holborow E. J., Hamilton E., Williams R. Increased C1q binding and arthritis in primary biliary cirrhosis. Gut. 1980 May;21(5):418–422. doi: 10.1136/gut.21.5.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Culp K. S., Fleming C. R., Duffy J., Baldus W. P., Dickson E. R. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc. 1982 Jun;57(6):365–370. [PubMed] [Google Scholar]
  9. Elson C. J., Scott D. G., Blake D. R., Bacon P. A., Holt P. D. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis. Ann Rheum Dis. 1983 Apr;42(2):147–150. doi: 10.1136/ard.42.2.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fakunle Y. M., Aranguibel F., de Villiers D., Thomas H. C., Sherlock S. Monomeric (7S) IgM in chronic liver disease. Clin Exp Immunol. 1979 Nov;38(2):204–210. [PMC free article] [PubMed] [Google Scholar]
  11. Garner C. M., Mills C. O., Elias E., Neuberger J. M. The effect of bile salts on human vascular endothelial cells. Biochim Biophys Acta. 1991 Jan 10;1091(1):41–45. doi: 10.1016/0167-4889(91)90219-n. [DOI] [PubMed] [Google Scholar]
  12. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jones E. A., James S. P. Circulating immune complexes and the pathogenesis of primary biliary cirrhosis. Gastroenterology. 1982 Sep;83(3):709–711. [PubMed] [Google Scholar]
  14. Lindgren S., Johnson U. Complement activation in primary biliary cirrhosis: an in vitro model. J Lab Clin Med. 1985 Apr;105(4):432–435. [PubMed] [Google Scholar]
  15. Rai G. S., Hamlyn A. N., Dahl M. G., Morley A. R., Wilkinson R. Primary biliary cirrhosis, cutaneous capillaritis, and IgM-associated membranous glomerulonephritis. Br Med J. 1977 Mar 26;1(6064):817–817. doi: 10.1136/bmj.1.6064.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schifferli J. A., Ng Y. C., Peters D. K. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med. 1986 Aug 21;315(8):488–495. doi: 10.1056/NEJM198608213150805. [DOI] [PubMed] [Google Scholar]
  17. Sherlock S., Scheuer P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973 Sep 27;289(13):674–678. doi: 10.1056/NEJM197309272891306. [DOI] [PubMed] [Google Scholar]
  18. Short P. E., Williams C. E., Picken A. M., Hill F. G. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci. 1982 Oct;39(4):351–355. [PubMed] [Google Scholar]
  19. Spengler U., Pape G. R., Hoffmann R. M., Johnson J. P., Eisenburg J., Paumgartner G., Riethmüller G. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology. 1988 May-Jun;8(3):459–462. doi: 10.1002/hep.1840080304. [DOI] [PubMed] [Google Scholar]
  20. Thomas H. C., Potter B. J., Sherlock S. Is primary biliary cirrhosis an immune complex disease? Lancet. 1977 Dec 17;2(8051):1261–1263. doi: 10.1016/s0140-6736(77)92666-6. [DOI] [PubMed] [Google Scholar]
  21. Wakefield A. J., Sawyerr A. M., Dhillon A. P., Pittilo R. M., Rowles P. M., Lewis A. A., Pounder R. E. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet. 1989 Nov 4;2(8671):1057–1062. doi: 10.1016/s0140-6736(89)91078-7. [DOI] [PubMed] [Google Scholar]
  22. Wands J. R., Dienstag J. L., Bhan A. K., Feller E. R., Isselbacher K. J. Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med. 1978 Feb 2;298(5):233–237. doi: 10.1056/NEJM197802022980502. [DOI] [PubMed] [Google Scholar]
  23. Woolf A. D., Wakerley G., Wallington T. B., Scott D. G., Dieppe P. A. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis. 1987 Jun;46(6):441–447. doi: 10.1136/ard.46.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES